Angela Thedinga
CIK 1804588 · Chief Technology Officer · last filed 2026-06-11
Angela Thedinga is a Chief Technology Officer who has filed 9 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for NKTX, was dated Jun 11, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTX | Director | — | $2.86 | — | $0 | 6 | 2026-06-11 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Chief Technology Officer | 150,000 | $4.36 | $654.0K | $0 | 3 | 2021-08-10 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2022-03-29 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2021-02-18 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-25 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |